BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 19047104)

  • 1. Silibinin inhibits established prostate tumor growth, progression, invasion, and metastasis and suppresses tumor angiogenesis and epithelial-mesenchymal transition in transgenic adenocarcinoma of the mouse prostate model mice.
    Singh RP; Raina K; Sharma G; Agarwal R
    Clin Cancer Res; 2008 Dec; 14(23):7773-80. PubMed ID: 19047104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stage-specific inhibitory effects and associated mechanisms of silibinin on tumor progression and metastasis in transgenic adenocarcinoma of the mouse prostate model.
    Raina K; Rajamanickam S; Singh RP; Deep G; Chittezhath M; Agarwal R
    Cancer Res; 2008 Aug; 68(16):6822-30. PubMed ID: 18701508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of silibinin on the growth and progression of primary lung tumors in mice.
    Singh RP; Deep G; Chittezhath M; Kaur M; Dwyer-Nield LD; Malkinson AM; Agarwal R
    J Natl Cancer Inst; 2006 Jun; 98(12):846-55. PubMed ID: 16788158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dietary feeding of silibinin inhibits prostate tumor growth and progression in transgenic adenocarcinoma of the mouse prostate model.
    Raina K; Blouin MJ; Singh RP; Majeed N; Deep G; Varghese L; Glodé LM; Greenberg NM; Hwang D; Cohen P; Pollak MN; Agarwal R
    Cancer Res; 2007 Nov; 67(22):11083-91. PubMed ID: 18006855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth inhibition and regression of lung tumors by silibinin: modulation of angiogenesis by macrophage-associated cytokines and nuclear factor-kappaB and signal transducers and activators of transcription 3.
    Tyagi A; Singh RP; Ramasamy K; Raina K; Redente EF; Dwyer-Nield LD; Radcliffe RA; Malkinson AM; Agarwal R
    Cancer Prev Res (Phila); 2009 Jan; 2(1):74-83. PubMed ID: 19139021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Silibinin inhibits colorectal cancer growth by inhibiting tumor cell proliferation and angiogenesis.
    Singh RP; Gu M; Agarwal R
    Cancer Res; 2008 Mar; 68(6):2043-50. PubMed ID: 18339887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isosilibinin inhibits advanced human prostate cancer growth in athymic nude mice: comparison with silymarin and silibinin.
    Deep G; Raina K; Singh RP; Oberlies NH; Kroll DJ; Agarwal R
    Int J Cancer; 2008 Dec; 123(12):2750-8. PubMed ID: 18798272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Silibinin suppresses growth of human prostate carcinoma PC-3 orthotopic xenograft via activation of extracellular signal-regulated kinase 1/2 and inhibition of signal transducers and activators of transcription signaling.
    Singh RP; Raina K; Deep G; Chan D; Agarwal R
    Clin Cancer Res; 2009 Jan; 15(2):613-21. PubMed ID: 19147767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of advanced human prostate tumor growth in athymic mice by silibinin feeding is associated with reduced cell proliferation, increased apoptosis, and inhibition of angiogenesis.
    Singh RP; Sharma G; Dhanalakshmi S; Agarwal C; Agarwal R
    Cancer Epidemiol Biomarkers Prev; 2003 Sep; 12(9):933-9. PubMed ID: 14504208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Silibinin inhibits fibronectin induced motility, invasiveness and survival in human prostate carcinoma PC3 cells via targeting integrin signaling.
    Deep G; Kumar R; Jain AK; Agarwal C; Agarwal R
    Mutat Res; 2014 Oct; 768():35-46. PubMed ID: 25285031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Silibinin feeding alters the metabolic profile in TRAMP prostatic tumors: 1H-NMRS-based metabolomics study.
    Raina K; Serkova NJ; Agarwal R
    Cancer Res; 2009 May; 69(9):3731-5. PubMed ID: 19366793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of prostate carcinogenesis by dietary supplementation of celecoxib in transgenic adenocarcinoma of the mouse prostate model.
    Gupta S; Adhami VM; Subbarayan M; MacLennan GT; Lewin JS; Hafeli UO; Fu P; Mukhtar H
    Cancer Res; 2004 May; 64(9):3334-43. PubMed ID: 15126378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Silibinin inhibits hypoxia-induced HIF-1α-mediated signaling, angiogenesis and lipogenesis in prostate cancer cells: In vitro evidence and in vivo functional imaging and metabolomics.
    Deep G; Kumar R; Nambiar DK; Jain AK; Ramteke AM; Serkova NJ; Agarwal C; Agarwal R
    Mol Carcinog; 2017 Mar; 56(3):833-848. PubMed ID: 27533043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Silibinin suppresses in vivo growth of human prostate carcinoma PC-3 tumor xenograft.
    Singh RP; Deep G; Blouin MJ; Pollak MN; Agarwal R
    Carcinogenesis; 2007 Dec; 28(12):2567-74. PubMed ID: 17916909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Silibinin inhibits prostate cancer invasion, motility and migration by suppressing vimentin and MMP-2 expression.
    Wu KJ; Zeng J; Zhu GD; Zhang LL; Zhang D; Li L; Fan JH; Wang XY; He DL
    Acta Pharmacol Sin; 2009 Aug; 30(8):1162-8. PubMed ID: 19578386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regression of mouse prostatic intraepithelial neoplasia by nonsteroidal anti-inflammatory drugs in the transgenic adenocarcinoma mouse prostate model.
    Narayanan BA; Narayanan NK; Pittman B; Reddy BS
    Clin Cancer Res; 2004 Nov; 10(22):7727-37. PubMed ID: 15570007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemopreventive efficacy of inositol hexaphosphate against prostate tumor growth and progression in TRAMP mice.
    Raina K; Rajamanickam S; Singh RP; Agarwal R
    Clin Cancer Res; 2008 May; 14(10):3177-84. PubMed ID: 18483386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apigenin attenuates insulin-like growth factor-I signaling in an autochthonous mouse prostate cancer model.
    Shukla S; MacLennan GT; Fu P; Gupta S
    Pharm Res; 2012 Jun; 29(6):1506-17. PubMed ID: 22139534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral silibinin inhibits in vivo human bladder tumor xenograft growth involving down-regulation of survivin.
    Singh RP; Tyagi A; Sharma G; Mohan S; Agarwal R
    Clin Cancer Res; 2008 Jan; 14(1):300-8. PubMed ID: 18172282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Silibinin reverses epithelial-to-mesenchymal transition in metastatic prostate cancer cells by targeting transcription factors.
    Wu K; Zeng J; Li L; Fan J; Zhang D; Xue Y; Zhu G; Yang L; Wang X; He D
    Oncol Rep; 2010 Jun; 23(6):1545-52. PubMed ID: 20428808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.